US inflation expectations unmoved by coronavirus vaccine euphoria
|Two US drugmakers, Pfizer and Moderna, recently announced positive results of their respective experimental coronavirus vaccines, triggering hopes for a rise in inflation and the global economy returning to normalcy in 2021.
"Vaccine should ultimately be a boon for gold bugs, as the Fed could keep nominal rates capped while inflation expectations could firm further as a result," TD Securities strategists wrote on Wednesday.
While the US stocks have rallied to record highs on vaccine news, the inflation expectations have barely moved. The US 10-year breakeven rate, the bond market's gauge of long-term inflation expectations, remains steady near 1.7% versus 1.73% prior to Pfizer's announcement on Nov. 9, according to data source St. Louis Federal Reserve.
With the bond market pricing little rise in inflation on vaccine optimism, the equity market may be running ahead of itself.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.